On the use of PIPSA to guide target-selective drug design.
Henrich
Stefan
S
EML Research GmbH, Schloss-Wolfsbrunnenweg 33, 69118 Heidelberg, Germany. stefan.henrich@eml-r.villa-bosch.de
Richter
Stefan
S
Wade
Rebecca C
RC
D001419:Bacteria / Q000145:classification / Q000187:drug effects* / Q000201:enzymology; D001665:Binding Sites; D002176:Candida albicans / Q000187:drug effects* / Q000201:enzymology; D016503:Drug Delivery Systems; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000138:chemical synthesis; D006801:Humans; D008024:Ligands; D055672:Static Electricity; D013762:Tetrahydrofolate Dehydrogenase / Q000187:drug effects* / Q000378:metabolism
D004791:Enzyme Inhibitors; D008024:Ligands; D013762:Tetrahydrofolate Dehydrogenase